Schroder Investment Management Group’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
Other funds holding IMCR
RI
BG
TCM
VPC
AC
Schroder Investment Management Group's IMCR Position: Q2 2026 in Review
Schroder Investment Management Group sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 42,920 shares — an estimated $1.26M sold.
Schroder Investment Management Group first reported a position in IMCR in Q1 2022 and held it in 16 quarters. The position peaked at $13.2M in Q3 2022. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.
- Schroder Investment Management Group reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
- Schroder Investment Management Group sold 42,920 Immunocore shares in Q2 2026, an estimated $1.26M.
- Schroder Investment Management Group first reported a position in Immunocore in Q1 2022 and held it in 16 quarters.
- Schroder Investment Management Group's Immunocore position peaked at $13.2M in Q3 2022.
- 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.
Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.